Scholarlink

<p>Patients with hematologic malignancies are susceptible to neutropenic fever, a potentially life-threatening condition. This study investigated the association between clinical profiles, treatment, and outcomes in these patients. A retrospective analysis of 132 patients with first-time neutropenic fever and hematologic malignancy diagnosed at Tikur Anbessa Specialized Hospital, Ethiopia, between 2019-01-01 and 2019-12-31 was conducted. Data on demographics, underlying malignancy, presumed infection site, treatment, and 30-day mortality were collected. ale predominance (13:10) was observed. Acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) were the most common malignancies (43.2% and 40.9%, respectively). Chest focus of infection was the most frequent primary source (33%). Cefepime and Vancomycin combination therapy was used in 40.9% of patients. Prior febrile neutropenia and medical ICU admission during treatment significantly increased the odds of 30-day mortality (adjusted odds ratio 3.8 and 5.4, respectively). This study highlights the crucial role of prior febrile neutropenia and medical ICU admission in predicting mortality within 30 days of neutropenic fever diagnosis in patients with hematologic malignancies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical profile, treatment, and outcomes of febrile neutropenia in hematologic disorders: a look at 30-day mortality predictors

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月4日

查看全文
  • Eskedar Ferdu Azerefegne,
  • Gebeyehu Tessema Azibte,
  • Fitsum Seyoum Bekele,
  • Kehabtimer Shiferaw Kotiso,
  • Berhanu Moges Abera,
  • Bereket Abraha Molla,
  • Yonatan Habtamu Tamene,
  • Wondwossen Amogne Degu

摘要

Patients with hematologic malignancies are susceptible to neutropenic fever, a potentially life-threatening condition. This study investigated the association between clinical profiles, treatment, and outcomes in these patients. A retrospective analysis of 132 patients with first-time neutropenic fever and hematologic malignancy diagnosed at Tikur Anbessa Specialized Hospital, Ethiopia, between 2019-01-01 and 2019-12-31 was conducted. Data on demographics, underlying malignancy, presumed infection site, treatment, and 30-day mortality were collected. ale predominance (13:10) was observed. Acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) were the most common malignancies (43.2% and 40.9%, respectively). Chest focus of infection was the most frequent primary source (33%). Cefepime and Vancomycin combination therapy was used in 40.9% of patients. Prior febrile neutropenia and medical ICU admission during treatment significantly increased the odds of 30-day mortality (adjusted odds ratio 3.8 and 5.4, respectively). This study highlights the crucial role of prior febrile neutropenia and medical ICU admission in predicting mortality within 30 days of neutropenic fever diagnosis in patients with hematologic malignancies.